Sun Pharma Q4 FY26 Earnings Call Recording Available

• The document is a regulatory filing regarding the availability of an earnings call audio recording.
• The event type is an earnings call for Q4 FY26 results.
• The call was held on 22 May 2026, as referenced in the disclosure.
• This is a follow-up to a prior intimation regarding the earnings call dated 13th May 2026.
• The stated purpose is to make the audio recording of the earnings call available to investors.
• The audio recording is available on the company's website at the specific URL: https://sunpharma.com/wp-content/uploads/2026/05/FY26-Q4-Earnings-Call-Recording-10043382.mp3
• The disclosure is made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• Management participants are not listed in this specific disclosure.

Additional Notes Section

• No financial data, guidance references, or presentation summaries are included in this announcement.
• The document serves purely as a compliance filing to announce the availability of the earnings call recording.
• The filing is digitally signed by Anoop Deshpande, Company Secretary and Compliance Officer (ICSI Membership No.: A23983).